DIRS.INFO The most relevant business & tech news

☆ 'Mag 7' leads reversal — plus, we're adding a new stock to our Bullpen watchlist
▼ + stars: | 2024-11-19 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Next, we are going outside our current holdings and adding drugmaker Bristol Myers Squibb to the Bullpen, our watchlist of stocks that could join the portfolio. New Jersey-based Bristol Myers is in the midst of a transition phase under the leadership of new CEO Chris Boerner. Companies reporting earnings before the open Wednesday include Club stock TJX Companies , along with Target , Williams-Sonoma , and ZIM Integrated . THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Robert F, Kennedy Jr, Kennedy, Donald Trump, Wall, Eli Lilly, Bristol Myers, Chris Boerner, Boerner, Karuna, we'll, Stanley Black, Decker, Jim Cramer's, Jim Organizations: CNBC, ., Club, Nvidia, Dow Jones, of Health, Human Services, Senate, Bristol Myers Squibb, Bristol, pharma, Karuna Therapeutics, FDA, JPMorgan, Keysight Technologies, TJX Companies, Target, Williams, ZIM, Jim Cramer's Charitable Locations: New Jersey, U.S, Sonoma

☆ Cramer's Lightning Round: Eli Lilly is a buy
▼ + stars: | 2024-11-18 | by ( Julie Coleman | ) www.cnbc.com time to read: 1 min

Eli Lilly : "This stock is as hated now as it was loved not that long ago...I think that it is a buy." Cameco : "It is an incredibly expensive stock versus the rest of the market...I am a 'ka-ching ka-ching' when it comes to Cameco." Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter. Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market. Disclaimer The CNBC Investing Club Charitable Trust holds shares of Eli Lilly and Apple.

Persons: Eli Lilly, Jim Cramer's Organizations: Texas, CNBC, Club, Club Charitable Trust, Apple

☆ 2 health stocks are buys. They've been beaten up enough on Trump's RFK Jr. pick for HHS
▼ + stars: | 2024-11-18 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Following Monday's trade, Jim Cramer's Charitable Trust will own 550 shares of DHR, increasing its weighting to roughly 3.6% from 3.4%. Since the election, Danaher shares have fallen from $250 each to $230 while Eli Lilly shares have dropped from $806 to $720. LLY YTD mountain Eli Lilly YTD Eli Lilly shares fell from $903 to $846 after a disappointing third-quarter report where inventory destocking of its fast-selling GLP-1 medications caused the company to miss estimates and lower full-year guidance. But the possible appointment of RFK Jr. has created a whole host of uncertainty for Eli Lilly and the drug stocks at large. If you look out to 2026, Lilly shares are trading at roughly 24 times.

Persons: Jim Cramer's, Donald Trump, Robert F, Kennedy Jr, We're, Danaher, Eli Lilly, Bioprocessing, Eli Lilly's, Lilly, Jim Cramer, Jim Organizations: DHR, Care Sector Fund, Department of Health, Human Services, RFK Jr, National Institutes of Health, HHS, CNBC Locations: Danaher

☆ Lightning Round: Wait for a dip in Apple, says Jim Cramer
▼ + stars: | 2024-11-18 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Wait for a dip in Apple, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Sezzle, Eli Lilly, Coinbase, IES Holdings, Cameco, Marvell Technologies, and Apple.

Persons: Jim Cramer, Eli Lilly Organizations: IES Holdings, Cameco, Marvell Technologies, Apple Locations: Coinbase

☆ Weight-loss drug Wegovy launched in China
▼ + stars: | 2024-11-18 | by ( ) edition.cnn.com time to read: +1 min

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. The move intensifies the competition with Eli Lilly, which secured approval for its weight-loss drug in China in July but has yet to launch it. Both companies are ramping up production to capitalize on a weight-loss market projected by analysts to exceed $150 billion by the beginning of the next decade. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Novo (NVO) launched Wegovy in the US in 2021.

Persons: Eli Lilly, Novo, Wegovy Organizations: Novo Nordisk, drugmaker, Reuters Locations: China, United States

☆ Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
▼ + stars: | 2024-11-17 | by ( Lauren Kent | ) edition.cnn.com time to read: +8 min

London CNN —Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. Additional measures to prevent obesity in the first place are desperately needed, health experts say. Part of that new thinking is exploring weight loss drugs. The OHA has crunched the numbers on existing weight loss drugs like Wegovy, the brand name for the appetite suppressant semaglutide. “There is no such thing as a silver bullet for obesity,” the Obesity Health Alliance emphasized.

Persons: Wes Streeting, Streeting, Eli Lilly, It’s, Keir Starmer, ”, Alfred Slade, suppressant, ” Slade, “, it’s, Tom Little, prioritization, Jack Doughty, Martin White, ” White, White Organizations: London CNN, National Health Service, The Telegraph, Survey, British, Obesity Health Alliance, OHA, CNN, Reuters, Diabetes UK, NHS, of Health, Social Care, University of Cambridge Locations: United Kingdom, England, Novo Nordisk's, Denmark, sodas

☆ 5 new weight-loss drugs to watch in the fight for the next Ozempic
▼ + stars: | 2024-11-16 | by ( ) www.businessinsider.com time to read: +8 min

"Forthcoming medications take the blockbuster GLP-1 medications and up the ante." Like semaglutide (the active ingredient in Ozempic and Wegovy), it works on GLP-1, a hormone that regulates blood sugar and appetite. CagriSema adds it to the already-popular drug semaglutide, which itself helps manage hunger and blood sugar levels. "Longer-acting versions of GLP-1 medications offer the potential for greater convenience and potentially improved adherence and sustained use over time," McGowan said. Timeline: Data from Phase II trials is expected later this year, and planning is underway for Phase III trials.

Persons: Eli Lilly, Dr, Christopher McGowan, Eli Lilly's, Ozempic, retatrutide, VK2735, we've, they're, McGowan Organizations: Pharma, Novo Nordisk, Viking Therapeutics, Triple, Therapeutics, FDA, orforglipron, Nordisk, Reuters Locations: GLP, Mounjaro, California

☆ Three-Stock Lunch: Eli Lilly, Transdigm, & Nvidia
▼ + stars: | 2024-11-15 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Eli Lilly, Transdigm, & NvidiaLee Munson, president and CIO at Portfolio Wealth Advisors, joins CNBC’s ‘Power Lunch’ to discuss outlooks on three stocks: Eli Lilly, Transdigm, and Nvidia.

Persons: Eli Lilly, Transdigm, Nvidia Lee Munson Organizations: Nvidia, Wealth

☆ Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
▼ + stars: | 2024-11-15 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

Even with vaccine skeptic Robert F. Kennedy Jr. tapped to potentially lead the Department of Health and Human Services, CNBC's Jim Cramer said drug and junk food industries aren't necessarily headed for ruin. "Ultimately, if RFK dons jackboots and demands that we don't have vaccines or eat junk food, it probably won't matter," he said. At the same time, Cramer added, Kennedy has taken a hard stance against processed food. Many drug and processed food stocks have already shouldered heavy losses since Trump named Kennedy, including Eli Lilly , Bristol-Myers , Moderna , PepsiCo , J.M. Plus, he continued, drug and junk food stocks aren't particularly good investments during a rate-cutting cycle.

Persons: Robert F, Kennedy Jr, CNBC's Jim Cramer, Donald Trump, Kennedy, it's, Cramer, Kennedy's, Eli Lilly, Smucker, Mills, he's, Trump Organizations: Department of Health, Human Services, RFK, and Drug Administration, Centers for Disease Control, National Institutes of Health, HHS, Trump, Moderna, PepsiCo, J.M Locations: U.S, Bristol, Myers

☆ How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
▼ + stars: | 2024-11-15 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Shares of obesity drugmaker Eli Lilly fell more than 4% on Friday, extending a roughly 3% slide in Thursday's session. Ozempic is the posterchild of the fast-growing GLP-1 class, in which Novo Nordisk and Eli Lilly are currently the two dominant players. Bottom line Eli Lilly has been our favorite drug stock for years thanks to its stellar pipeline led by GLP-1s. But, at this point, Kennedy's nomination requires us to be more cautious on Eli Lilly in the near term. Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.

Persons: Eli Lilly, Donald Trump, Robert F, Kennedy Jr, Kentucky Sen, Rand Paul, Kennedy, Trump, Eli Lilly's, John F, Kennedy —, LLY, Eli Lilly's GLP, Jim Cramer, David Ricks, Lilly, It's, Jim, it's, Jim Cramer's, Cristina Arias Organizations: Republican, Department of Health, Human Services, HHS, and Drug Administration, Centers for Disease Control, Medicare, Medicaid, Senate, Democratic, GOP, Media, Novo Nordisk, Moderna, Pfizer, Deutsche Bank, GSK, White, CDC, Street Journal, GLP, Big Pharma, FDA, tirzepatide, CNBC, Company, Pharmaceutical Locations: Washington, Kentucky, Danish, U.S, Alcobendas, Madrid, Spain

☆ A tough week for stocks may soon force us to act. Here's where we would look to buy first
▼ + stars: | 2024-11-15 | by ( Jeff Marks | ) www.cnbc.com time to read: +6 min

Markets sink: Stocks are taking it on the chin Friday, capping off a week in which the S & P 500 fell about 2%. Bright spots : The two best-performing S & P 500 sectors this week are financials and energy. Health care was far and away the worst-performing group in the S & P 500. Next week: There's 11 companies in the S & P 500 reporting next week. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .

Persons: Jim Cramer, There's, Donald Trump's, Jerome Powell, Trump, –, Morgan Stanley, Wells Fargo, Robert F, Kennedy Jr, Eli Lilly, we'll, Stanley Black, Decker, Jim Cramer's, Jim Organizations: CNBC, Traders, – BlackRock, Energy, Coterra Energy, Disney, Department of Health, Human Services, pharma, Nvidia, Walmart, Viking Holdings, TJX Companies, Palo Alto Networks, Target, Williams, Club, BJ's, Ross Stores, Baidu, PDD Holdings, GE Healthcare, Jim Cramer's Charitable Locations: Wells Fargo, Sonoma, Snowflake, Palo Alto

☆ Billionaire investors were torn on Alphabet, Amazon. How they traded 5 portfolio stocks
▼ + stars: | 2024-11-15 | by ( Morgan Chittum | ) www.cnbc.com time to read: +5 min

Club holdings Alphabet and Amazon found themselves on the fault line. Battleground tech GOOGL YTD mountain Alphabet (GOOGL) year-to-date performance Third Point, the hedge fund run by Dan Loeb, sold its entire nearly $333 million position in Alphabet last quarter. Third Point trimmed its Amazon holdings by nearly 28%. A fund's holdings may very well have changed by the time the previous quarters' filings are revealed. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Wall, Dan Loeb, David Tepper, Seth Klarman, Philippe Laffont's Coatue, Bill Ackman's Pershing, Daniel Sundheim, Coatue, Donald Trump's, Eli Lilly, Jim Cramer's, Jim, Jim Cramer, Sebastien Bozon Organizations: Management, Group, D1, Amazon, Big Tech, Nasdaq, Health, D1 Capital, GE Healthcare, Jim Cramer's Charitable, CNBC, AFP, Getty Locations: 13Fs, Danaher

☆ Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
▼ + stars: | 2024-11-15 | by ( Pia Singh | In | ) www.cnbc.com time to read: +3 min

Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. Ulta slipped nearly 3% after Berkshire Hathaway revealed in a regulatory filing that it had sold around 97% of its shares, nearly dissolving its position in the beauty retailer. Berkshire had just bought the stock in the second quarter, making Ulta a relatively new bet. However, the company beat expectations on both lines in the fourth fiscal quarter and issued positive guidance for adjusted earnings per share.

Persons: Donald Trump, Robert F, Kennedy Jr, Eli Lilly, Warren Buffett, Berkshire Hathaway, Ulta, — CNBC's Sean Conlon, Alex Harring, Jesse Pound, Hakyung Kim, Lisa Han Organizations: Global pharma, Moderna, Pfizer, GSK, Novo Nordisk, Nasdaq, Securities and Exchange Commission, Super, New York Stock Exchange, Corp, Berkshire, Pool Corp, AST, Materials, LSEG Locations: China, Domino's, Berkshire

☆ Here are Thursday's biggest analyst calls: Nvidia, Netflix, Amazon, Microsoft, Tesla, Meta, Campbell Soup and more
▼ + stars: | 2024-11-14 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Thursday's biggest calls on Wall Street: Citi initiates Gilead Sciences as buy The firm said it is bullish on the biotech company's HIV franchise. Piper Sandler upgrades Campbell Soup to overweight from neutral Piper Sandler said it sees an attractive entry point for the stock. UBS initiates Cogent as buy The firm said it sees meaningful revenue acceleration for the internet services company. Jefferies reiterates Tesla as hold The firm raised its price target on the stock to $300 per share from $195. Morgan Stanley reiterates Meta as overweight The firm said Meta is a major artificial intelligence beneficiary. "

Persons: Piper Sandler, Campbell, Oppenheimer, Jefferies, Tesla, Morgan Stanley, Papa, KeyBanc, Papa John's, BXP, Wells, Wells Fargo, BURL, Meta, Needham, Eli Lilly's Organizations: Citi, Gilead Sciences, HIV, SOVO, UBS, Nvidia, Bank of America, Neutral Bank of America, ISI, Papa Johns International, Company, JPMorgan, Medicines, 3Q, Netflix, Barclays, Airlines, FDA, Novo Nordisk, Microsoft Locations: Europe, Asia, Africa, America, Manhattan, Burlington

☆ Philippe Laffont’s Coatue makes big bets on China and GLP-1 drugmakers in latest quarter
▼ + stars: | 2024-11-14 | by ( Pia Singh | In | ) www.cnbc.com time to read: +2 min

He also increased his stake in JD.com by 8.2 million shares, or 33,490%, and PDD Holdings by roughly 2.28 million shares, or 741%. Laffont also created new positions in iShares China Large-Cap ETF and KraneShares CSI China Internet ETF . Laffont also made a couple of significant increases to the fund's holdings in Eli Lilly and Novo Nordisk . Facebook parent Meta still remains the fund's largest holding, while Amazon, Microsoft and Nvidia remain in the fund's top 10. The filing also showed increased bets on Eaton Corporation, a name closely tied to the artificial intelligence-related energy infrastructure boom, as well as Constellation Energy and NextEra Energy .

Persons: Philippe Laffont's Coatue, Julian Robertson, Laffont, Donald Trump's, Xi Jinping, Eli Lilly Organizations: Philippe Laffont's Coatue Management, U.S . Securities, Exchange Commission, Tiger Management, PDD Holdings, KraneShares CSI China Internet, Novo Nordisk, Novo Nordisk's ADRs, Broadcom, Microsoft, Nvidia, chipmakers Qualcomm, Devices, Taiwan Semiconductor, Facebook, Amazon, Eaton Corporation, Constellation Energy, NextEra Energy Locations: Alibaba, JD.com, iShares China, China, Novo, chipmakers

Here's a rapid-fire update on all the stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. This time around, Trump's tariff proposals on Chinese imports could help Amazon in its competition against low-price online sellers Temu and Shein. Salesforce : Not a Trump stock, but it wasn't a Kamala Harris stock either. Constellation Brands : The Mexican beer importer has been punished on fears about what Trump's tariff and immigration proposals could do to its business. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Jim, Donald Trump's, Trump's, Abbott, Trump, Hock Tan, Tan, We'll, it's pricier, Morgan Stanley, Wells, Kamala Harris, Agentforce, That's, Biden, Dover, Eaton's, Elon, Waymo, JD Vance, we've, Linde, that's, Eli Lilly, Robert F, Kennedy Jr, Kennedy, Lilly, Mark Zuckerberg, Zuckerberg, Goldman Sachs, shouldn't, Nextracker, Brian Niccol, Niccol, Stanley Black, Decker, TJ Maxx, Wells Fargo, Jim Cramer Organizations: Jim Cramer's Charitable Trust, CNBC, Abbott Laboratories, Abbott Labs, White, Biden, AMD, Trump, Wednesday, Broadcom, VMWare, BlackRock, Costco, Coterra Energy, Coterra, DuPont, Disney, GE Healthcare, GE Aerospace, Google, Honeywell, Elliott Investment Management, Linde, Microsoft, Big Tech, Apple, Meta, Financial Times, Nvidia, Palo Alto Networks, Yum Brands, Taco Bell, Constellation Brands, Management, TJX, Marshalls, Jim Cramer's Charitable Locations: China, India, Missouri, Wells Fargo, BlackRock, Shanghai, Dover, U.S, Palo, HomeGoods

☆ This fund has outperformed the S&P 500 over the past 5 years. Here's how
▼ + stars: | 2024-11-13 | by ( Pia Singh | In | ) www.cnbc.com time to read: +7 min

Select Quality Equity Fund (GQEPX) is up 33% in 2024, outpacing the S & P 500's 27% year-to-date total return. It has also outperformed 99% of funds in its category over the past five years, per Morningstar. This matches the rest of the firm's fund strategies, GQG portfolio manager Brian Kersmanc told CNBC. "We focus on this concept of forward quality," Kersmanc explained. So they're considered that sort of a blue chip, almost widow-and-orphan stock within the portfolio," Kersmanc said.

Persons: Morningstar, GQEPX, Brian Kersmanc, Eli Lilly, Kersmanc, Rajiv Jain, it's, Philip Morris, —, It's, they're Organizations: GQG Partners, Equity Fund, CNBC, Nvidia, Exxon Mobil, Kersmanc, Exxon Locations: Florida, GQEPX

☆ This Trump trade is an underappreciated opportunity, says Janus Henderson
▼ + stars: | 2024-11-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Financial and energy stocks have jumped since last week's election, but there's another area of opportunity that investors could be missing out on, according to Janus Henderson. The market has rallied since President-elect Donald Trump' s victory, although it took a breather on Tuesday. However, financial stocks may have "gotten in a bit ahead of themselves," said Jeremiah Buckley, a portfolio manager at Janus Henderson. In addition, there is great research and development happening in health care right now, especially in health-care services, Buckley added. Among the funds Buckley oversees at Janus Henderson is the U.S. Dividend Income Fund .

Persons: Janus Henderson, Donald Trump, Jeremiah Buckley, Trump, Buckley, Eli Lilly, Amgen Organizations: Trump, P Health Care Services, UnitedHealth, Gilead Sciences

☆ Amgen stock falls as analysts mull over weight loss drug’s bone density data
▼ + stars: | 2024-11-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. Amgen did not immediately respond to a request for comment on the dataThe drug is a promising potential competitor in the weight loss drug market. "On one hand, patients could naturally lose bone mineral density during weight loss treatment," Brayer wrote. But Brayer said, "on the other hand, this could be a non-starter because there seems to be a dose-dependent increase" in bone mineral density loss. Amgen is also aware of the "hypothetical concern" of bone mineral density loss, Yee said, citing the firm's discussions with management.

Persons: Amgen, Eli Lilly, Cantor Fitzgerald, Olivia Brayer, Eli, Wegovy, Brayer, Jefferies, Michael Yee, Yee, Evan Seigerman, hasn't, Seigerman Organizations: Novo Nordisk, BMO

☆ Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise
▼ + stars: | 2024-11-08 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Eli Lilly: Shares of Eli Lilly are finally putting together back-to-back sessions of gains. Eli Lilly shares traded at $903 before the quarterly report, putting the post-earnings pullback at about 7%. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.

Persons: Jim Cramer, Donald Trump's, aren't, Eli Lilly, Lilly, David Ricks, Wells, We've, Eli Lilly's, Tyson, Jim Cramer's, Jim, Shelby Knowles Organizations: CNBC, ., Treasury, Companies, Tech, Tesla, Arista Networks, Costco, United States, Disney, Tyson Foods, AstraZeneca, Spotify, Occidental, Cisco, Advance, Materials, Jim Cramer's Charitable, Bloomberg, Getty Locations: China, Wells Fargo, Brooklyn, New York

☆ Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more
▼ + stars: | 2024-11-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Morgan Stanley reiterates Live Nation as overweight Morgan Stanley raised its price target on the stock to $140 per share from $120. Bank of America reiterates Apple as buy Bank of America says it sees "limited" impact to Apple earnings regardless of the Presidential outcome. Bank of America reiterates Palantir as buy The firm says Palantir is an AI "juggernaut" following earnings on Monday. Bank of America reiterates Arista Networks as buy Bank of America says it sees share gains ahead for the networking equipment company. Morgan Stanley reinstates Krispy Kreme as equal weight Morgan Stanley says Krispy Kreme has a balanced risk/reward right now.

Persons: Morgan Stanley, it's bullish, Eli Lilly, Palantir, Bernstein, Eaton, Deutsche, there's, Jefferies, Rick Dreiling, MTZ, Morgan Stanley reinstates Krispy, Krispy Kreme Organizations: Bank of America, Boeing, JPMorgan, RBC, Microsoft, " Bank of America, Broadcom, Apple, Republicans, Arista Networks, Arista, Meta, Deutsche Bank, eBay, Barclays, Energy, Infrastructure, Communications, Resources, IDA Locations: San Antonio, Redmond , WA

☆ Company executives are speaking out on Election Day: Starbucks' Howard Schultz calls for a peaceful transition of power
▼ + stars: | 2024-11-05 | by ( Grace Eliza Goodwin | ) www.businessinsider.com time to read: +9 min

Business leaders are speaking out on Election Day — including Starbucks founder Howard Schultz. AdvertisementElection Day has finally come, and executives at some of the biggest companies are speaking out — with former Starbucks CEO Howard Schultz urging a peaceful transition of power and Elon Musk reiterating his support for Donald Trump to the end. Major players like Musk and Blackstone CEO Stephen Schwarzman have previously endorsed former President Trump. "Once every vote is counted and certified, we must accept the results of the election and ensure the peaceful transition of power," he said. In addition to re-posting several pro-Trump messages from other X users, Musk wrote a few election-related posts of his own.

Persons: Howard Schultz, Schultz, Elon Musk, Reid Hoffman, Harris, —, Donald Trump, Stephen Schwarzman, Trump, Mark Cuban, Kamala Harris, Insider's Bryan Metzger, he's, Howard Schultz Howard Schultz, Spencer Platt, Joe Biden, Hillary Clinton, Reid Hoffman Reid Hoffman, Kimberly White, Hoffman, " Hoffman, Marc Piasecki, Musk, Joe Scarborough, Vinod Khosla Vinod Khosla, Steven Ferdman, Vinod Khosla, Kamala, Khosla, Robert F, Kennedy Jr, Cantor Fitzgerald, Howard Lutnick Howard Lutnick, ANGELA WEISS, Howard Lutnick, Lutnick, Palmer Luckey Palmer Luckey, Oculus, Patrick T, Fallon, Palmer, Luckey, Walz, Andrew Bosworth, JOSH EDELSON, Getty Andrew Bosworth, Bosworth, Eli Lilly, Lockheed Martin, General Mills, Johnson Organizations: Starbucks, Trump, Service, Blackstone, Getty, LinkedIn, Greylock Partners, Liberty, SpaceX, Elon Musk Elon, Tesla, Pennsylvania, Billionaire, Sun Microsystems, Wall Street, Philadelphia Inquirer, Financial Times, Bloomberg, Anduril Industries, Meta, Big Tech, National Association of Manufacturers, General Motors, Penske, Panasonic Locations: Jerusalem, Fortnite, AFP

☆ JPMorgan’s favorite stock picks heading into November
▼ + stars: | 2024-11-04 | by ( Sean Conlon | ) www.cnbc.com time to read: +4 min

With the election around the corner, JPMorgan has updated its top ideas list that target growth, income, value and short-selling strategies. Yet, JPMorgan thinks that trajectory can keep going, as it has an overweight rating on the stock with a $300 price target. JPMorgan's overweight rating and target of $1,100 on the name also implies more than 34% upside from here. JPMorgan also highlighted the newly added Regency Centers as one of its growth strategies for the new trading month. Shares have jumped more than 7% this year, and JPMorgan's target implies almost 8% upside from Friday's close, on par with its average target of $77.12.

Persons: JPMorgan's, Carvana, Eli Lilly, David Ricks Organizations: JPMorgan, Nasdaq, Dow Jones Industrial, Regency Centers, Caterpillar Locations: Carvana

☆ Cramer raves about Salesforce's star-powered plan to raise awareness of its new AI agents
▼ + stars: | 2024-11-04 | by ( Matthew J. Belvedere | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. In his Sunday column, meanwhile, Jim Cramer looked at 11 earnings surprises , including a feeling that both presidential candidates would support solar. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, There's, that's, there's, Eli Lilly, Lilly, Stanley Black, Decker, Nextracker, Jim, Salesforce, Evercore, Agentforce, he's, Saleforce's, Matthew McConaughey, Stocks, Sherwin, Berkshire Hathaway, Jim Cramer's, NVDA Organizations: CNBC, Fed, Devices, Nvidia, Intel, Dow, Therapeutics, Depot, ISI, Abercrombie, Fitch, Constellation Energy Locations: Friday's, Williams, Berkshire, Marriott

☆ Stocks making the biggest moves premarket: Trump Media, Talen, Nvidia, Apple and more
▼ + stars: | 2024-11-04 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

The drug is classified as a GLP-1, which could put the company in competition with Novo Nordisk and Eli Lilly. Berkshire Hathaway – Shares were marginally lower after Warren Buffett's conglomerate revealed that operating earnings totaled $10.1 billion in the third quarter . Berkshire Hathaway shares were marginally lower after operating earnings totaled $10.1 billion in the third quarter. Trump Media & Technology Group – Shares of former President Donald Trump's media company pulled back more than 3% ahead of the U.S. election on Tuesday. Shares of Intel were more than 1% lower, while Dow Inc. shares were off 0.6%.

Persons: Talen, Eli Lilly, Berkshire Hathaway, Warren Buffett's, Warren Buffett's Berkshire Hathaway, Peter Stern, Donald Trump's, Roblox, Morgan Stanley, Jefferies, Sherwin, Williams, William, CNBC's Hakyung Kim, Brian Evans, Sarah Min, Lisa Kailai Han, Spencer Kimball, Tanaya Macheel, Michelle Fox Theobald Organizations: Energy, Federal Energy Regulatory Commission, Susquehanna, Constellation, Therapeutics, Novo Nordisk, Apple, Berkshire, –, Bank of America, Trump Media & Technology, Nvidia, Dow Jones, Intel, Dow Inc

Search resuls for: "Eli Lilly"

25 mentions found